Sainte Croix de Quintillargues, France

Alain Roccon



Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Antony, FR (2010)
  • Sainte-Croix-de-Quintillargues, FR (2012)

Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Alain Roccon

Introduction

Alain Roccon is a notable inventor based in Sainte Croix de Quintillargues, France. He has made significant contributions to the field of medicinal products, particularly in the treatment of pulmonary hypertension. With a total of two patents to his name, Roccon's work showcases his dedication to advancing medical science.

Latest Patents

Roccon's latest patents include the use of irbesartan for the preparation of medicinal products that are useful for treating pulmonary hypertension. This invention focuses on the application of irbesartan in preventing or treating pulmonary arterial hypertension. Another significant patent involves indolizine derivatives, which details a method for preparing novel indolizine compounds and their therapeutic compositions.

Career Highlights

Alain Roccon is associated with Sanofi-Aventis, a leading global pharmaceutical company. His work at Sanofi-Aventis has allowed him to collaborate with other talented professionals in the field, contributing to innovative solutions in medicine.

Collaborations

Roccon has worked alongside notable colleagues such as Patrick Gautier and David Marchionni. Their combined expertise has fostered a collaborative environment that enhances the development of new therapeutic products.

Conclusion

Alain Roccon's contributions to the field of medicinal inventions, particularly in pulmonary hypertension, highlight his innovative spirit and commitment to improving healthcare. His patents reflect a significant advancement in medical treatments, showcasing the importance of research and collaboration in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…